© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, AVITA Medical, Inc. (RCEL) shows an Average True Range (ATR) of 0.37 and an Enterprise Value of 172.2M. Its average trading volume over the past 3 months is 226.51K, indicating liquidity. These fundamental metrics provide insight into RCEL's underlying financial health and market activity.
| ATR | 0.37 |
| Enterprise Value | 172.2M |
| Avg Vol (3 Months) | 226.51K |
| Avg Vol (10 Days) | 147.56K |
AVITA Medical, Inc. (RCEL) technical indicators as of March 17, 2026: the SMA 20 is 17.3%, SMA 50 at 30.48%, and SMA 200 at 8.12%. The RSI 14 value is 66.49, suggesting its current momentum. These technical analysis signals help assess RCEL's price trends and potential future movements.
| SMA 20 | 17.3% |
| SMA 50 | 30.48% |
| SMA 200 | 8.12% |
| RSI 14 | 66.49 |
AVITA Medical, Inc. (RCEL) stock performance overview as of March 17, 2026: The 52-week high is $10.29 (currently -50.34% below), and the 52-week low is $3.22 (currently 58.7% above). Over the past year, RCEL's performance is -55.85%, compared to the S&P 500's 16.38% change.
| 52-Week High | 10.29 |
| 52-Week High Chg | -50.34% |
| 52-Week Low | 3.22 |
| 52-Week Low Chg | +58.70% |
| S&P 500 52-Week Chg | 16.38% |
According to market data, AVITA Medical, Inc. (RCEL) stock's recent performance metrics show that over the last month, RCEL is 15.29%, with a Year-to-Date (YTD) performance of 9.28%. Over the past year, the stock has seen a -55.85% change. These figures summarize RCEL's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 5.13 | 5.92 | 5.92 | 7.12 | 10.29 | 5.92 |
| Low | 4.29 | 3.52 | 3.22 | 3.22 | 3.22 | 3.22 |
| Performance | +10.23% | +15.29% | -5.51% | -27.64% | -55.85% | +9.28% |
According to current financial data, RCEL stock's P/E (TTM) ratio is -2.87, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for RCEL, including P/S (1.59), P/B (-8.39), and P/FCF (-3.66), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | RCEL | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -2.87 | -1.23 | -26.18 | 32.59 |
| P/S (TTM) | 1.59 | 3.71 | 14.12 | 5.98 |
| P/B (TTM) | -8.39 | N/A | -8.34 | 4.58 |
| P/FCF (TTM) | -3.66 | 13.54 | -16.24 | 31.82 |